1. Home
  2. AGIO vs ACMR Comparison

AGIO vs ACMR Comparison

Compare AGIO & ACMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AGIO
  • ACMR
  • Stock Information
  • Founded
  • AGIO 2007
  • ACMR 1998
  • Country
  • AGIO United States
  • ACMR United States
  • Employees
  • AGIO N/A
  • ACMR N/A
  • Industry
  • AGIO Biotechnology: Pharmaceutical Preparations
  • ACMR Industrial Machinery/Components
  • Sector
  • AGIO Health Care
  • ACMR Technology
  • Exchange
  • AGIO Nasdaq
  • ACMR Nasdaq
  • Market Cap
  • AGIO 2.4B
  • ACMR 2.5B
  • IPO Year
  • AGIO 2013
  • ACMR 2017
  • Fundamental
  • Price
  • AGIO $41.13
  • ACMR $42.13
  • Analyst Decision
  • AGIO Strong Buy
  • ACMR Buy
  • Analyst Count
  • AGIO 4
  • ACMR 4
  • Target Price
  • AGIO $59.33
  • ACMR $34.67
  • AVG Volume (30 Days)
  • AGIO 514.0K
  • ACMR 1.2M
  • Earning Date
  • AGIO 10-30-2025
  • ACMR 11-05-2025
  • Dividend Yield
  • AGIO N/A
  • ACMR N/A
  • EPS Growth
  • AGIO N/A
  • ACMR 31.61
  • EPS
  • AGIO 11.13
  • ACMR 1.66
  • Revenue
  • AGIO $40,875,000.00
  • ACMR $815,166,000.00
  • Revenue This Year
  • AGIO $23.74
  • ACMR $18.90
  • Revenue Next Year
  • AGIO $159.90
  • ACMR $16.78
  • P/E Ratio
  • AGIO $3.77
  • ACMR $25.45
  • Revenue Growth
  • AGIO 30.57
  • ACMR 17.53
  • 52 Week Low
  • AGIO $23.42
  • ACMR $13.87
  • 52 Week High
  • AGIO $62.58
  • ACMR $45.12
  • Technical
  • Relative Strength Index (RSI)
  • AGIO 50.11
  • ACMR 59.03
  • Support Level
  • AGIO $41.24
  • ACMR $40.39
  • Resistance Level
  • AGIO $44.25
  • ACMR $42.92
  • Average True Range (ATR)
  • AGIO 1.52
  • ACMR 1.77
  • MACD
  • AGIO -0.16
  • ACMR -0.05
  • Stochastic Oscillator
  • AGIO 31.28
  • ACMR 83.77

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.

About ACMR ACM Research Inc.

ACM Research Inc supplies advanced, innovative capital equipment developed for the world-wide semiconductor industry. Fabricators of advanced integrated circuits, or chips, can use its wet-cleaning and other front-end processing tools in numerous steps to improve product yield, even at increasingly advanced process nodes. It has designed these tools for use in fabricating foundry, logic and memory chips, including dynamic random-access memory, or DRAM, and 3D NAND-flash memory chips. The company also develops, manufactures and sells advanced packaging tools to wafer assembly and packaging customers.

Share on Social Networks: